BCDA
Price
$2.15
Change
-$0.08 (-3.59%)
Updated
Jun 27 closing price
Capitalization
11.03M
SMMT
Price
$20.60
Change
-$0.67 (-3.15%)
Updated
Jun 27 closing price
Capitalization
15.3B
39 days until earnings call
Interact to see
Advertisement

BCDA vs SMMT

Header iconBCDA vs SMMT Comparison
Open Charts BCDA vs SMMTBanner chart's image
BioCardia
Price$2.15
Change-$0.08 (-3.59%)
Volume$26.7K
Capitalization11.03M
Summit Therapeutics
Price$20.60
Change-$0.67 (-3.15%)
Volume$14.09M
Capitalization15.3B
BCDA vs SMMT Comparison Chart in %
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCDA vs. SMMT commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a Hold and SMMT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (BCDA: $2.15 vs. SMMT: $20.60)
Brand notoriety: BCDA and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 33% vs. SMMT: 274%
Market capitalization -- BCDA: $11.03M vs. SMMT: $15.3B
BCDA [@Biotechnology] is valued at $11.03M. SMMT’s [@Biotechnology] market capitalization is $15.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileSMMT’s FA Score has 1 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • SMMT’s FA Score: 1 green, 4 red.
According to our system of comparison, SMMT is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 4 TA indicator(s) are bullish while SMMT’s TA Score has 5 bullish TA indicator(s).

  • BCDA’s TA Score: 4 bullish, 3 bearish.
  • SMMT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BCDA and SMMT are a good buy in the short-term.

Price Growth

BCDA (@Biotechnology) experienced а +3.37% price change this week, while SMMT (@Biotechnology) price change was +0.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

SMMT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($15.3B) has a higher market cap than BCDA($11M). SMMT YTD gains are higher at: 15.439 vs. BCDA (-1.376). BCDA has higher annual earnings (EBITDA): -8.39M vs. SMMT (-235.08M). SMMT has more cash in the bank: 361M vs. BCDA (949K). BCDA has less debt than SMMT: BCDA (850K) vs SMMT (6.45M). BCDA has higher revenues than SMMT: BCDA (3K) vs SMMT (0).
BCDASMMTBCDA / SMMT
Capitalization11M15.3B0%
EBITDA-8.39M-235.08M4%
Gain YTD-1.37615.439-9%
P/E RatioN/A26.41-
Revenue3K0-
Total Cash949K361M0%
Total Debt850K6.45M13%
FUNDAMENTALS RATINGS
BCDA vs SMMT: Fundamental Ratings
BCDA
SMMT
OUTLOOK RATING
1..100
736
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
10045
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6241
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCDA's Valuation (91) in the null industry is in the same range as SMMT (95) in the Biotechnology industry. This means that BCDA’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (45) in the Biotechnology industry is somewhat better than the same rating for BCDA (100) in the null industry. This means that SMMT’s stock grew somewhat faster than BCDA’s over the last 12 months.

SMMT's SMR Rating (98) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that SMMT’s stock grew similarly to BCDA’s over the last 12 months.

SMMT's Price Growth Rating (41) in the Biotechnology industry is in the same range as BCDA (62) in the null industry. This means that SMMT’s stock grew similarly to BCDA’s over the last 12 months.

SMMT's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for BCDA (100) in the null industry. This means that SMMT’s stock grew significantly faster than BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDASMMT
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
79%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LSGR41.690.41
+0.99%
Natixis Loomis Sayles Focused Growth ETF
KYN12.590.09
+0.72%
Kayne Anderson Energy Infrastructure Fund
DALI26.290.14
+0.52%
First Trust Dorsey Wright DALI 1 ETF
PEPS25.56N/A
N/A
Parametric Equity Plus ETF
BHV10.32-0.11
-1.05%
BlackRock Virginia Muni

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with RNAC. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
-3.59%
RNAC - BCDA
85%
Closely correlated
-6.81%
CDTX - BCDA
85%
Closely correlated
+0.24%
AGEN - BCDA
85%
Closely correlated
-3.05%
NBY - BCDA
84%
Closely correlated
+0.97%
WINT - BCDA
84%
Closely correlated
+21.49%
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
-3.15%
BCDA - SMMT
69%
Closely correlated
-3.59%
BNTX - SMMT
52%
Loosely correlated
+0.55%
TIL - SMMT
52%
Loosely correlated
+3.61%
RLAY - SMMT
45%
Loosely correlated
-0.60%
CRNX - SMMT
41%
Loosely correlated
-1.48%
More